Insider · CIK 0001883000
Judith Anne Shizuru
Files at JSPR (Jasper Therapeutics, Inc.). First filing Sep 24, 2025, latest Sep 24, 2025.
Judith Anne Shizuru files SEC Form 4 as director at JSPR (Jasper Therapeutics, Inc.). Since Sep 24, 2025, Judith Anne Shizuru has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on Sep 24, 2025.
A track record needs three past buys with six months of prices behind them; Judith Anne Shizuru has 0, so none is measured yet.
The newest scored trade: bought $100k of JSPR on Sep 22, 2025, filed Sep 24, 2025, scored 64 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JSPR: Jasper Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | Jasper Therapeutics, Inc. | $100k 41,000 shares | +35% | +9% from low-90% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | POpen-market purchase Voting Common Stock | +41,000 | $2.43 | $100k | 156,901 | Sep 24, 2025 |
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | POpen-market purchase Common Stock Warrant (right to buy)derivative | +41,000 | - | - | 41,000 | Sep 24, 2025 |
| Jul 3, 2025 | JSPR Jasper Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,500 | $0.00 | $0 | 7,500 | Jul 3, 2025 |
Questions about Judith Anne Shizuru
Answered from the filings on this page, as of the latest one.
Is Judith Anne Shizuru buying or selling?
Not in the last 12 months. Judith Anne Shizuru's latest open-market trade on SEC Form 4 was bought $100k of JSPR on Sep 22, 2025.
How did Judith Anne Shizuru's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Judith Anne Shizuru has 0.
Where does Judith Anne Shizuru file Form 4?
Judith Anne Shizuru has filed Form 4 at JSPR (Jasper Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.